Sigrima – 420mg

Sigrima 420mg Injection, is a targeted therapy containing the active constituents pertuzumab and trasrtuzumab. It is used to treat a type of breast cancer (human epidermal growth factor receptor 2 positive breast cancer) that has spread to other parts of the body (metastasized) or cancer that has come back after the treatment. It will also be given before or after the surgery if the cancer has not metastasized. Cancer occurs when cells begin to grow abnormally in an uncontrolled manner.

Brand Name	Sigrima 420mg
Compostion	PERTUZUMAB
Country of origin	Made in India
Form	Injection
Manufacturer	Zydus Cadila
Packaging Type	Vial
Strength	420 mg
Shelf Life	2 Year

Category: Pharmaceutical Injection

Description

Before taking Sigrima 420mg Injection, talk to the physician if you have heart problems, have had radiotherapy, or have allergic conditions. This medication is not recommended for adolescents and children under 18. In patients with early-stage HER2-positive breast cancer, adding pertuzumab or trastuzumab to standard chemotherapy can reduce the risk of recurrence and improve disease-free survival.

Sigrima 420mg Injection is given as an injection into veins under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Explore more products Pharmaceutical Injection

Pharmaceutical Injection – Globmedindia

Additional information

Brand Name	Sigrima 420mg
Compostion	PERTUZUMAB
Country of origin	Made in India
Form	Injection
Manufacturer	Zydus Cadila
Packaging Type	Vial
Strength	420 mg
Shelf Life	2 Year